Seroprevalence and fetal prognosis of hiv infection during pregnancy at cocody chu

Author: 
Kouakou C., Djivohessoun A., Dainguy M E., Gro Bi A., Djoman A., Mansou A., Kouadio E., Angan G and Folquet A M

The objective of this work was to determine the prevalence and to evaluate the fetal prognosis of HIV infection during pregnancy.
Population and method: This was a retrospective descriptive and analytical study that took place from October 1, 2016 to July 31, 2017 in the delivery room of the Gynecology and Obstetrics Department of the Cocody CHU. Included were pregnant women who came to give birth and who tested positive for HIV. The parameters studied in pregnant women were: age, occupation, nationality, gestationality, parity, antenatal care (ANC), delivery mode, indication of cesarean section and CD4 count. The neonatal parameters studied were age of pregnancy, Apgar index at birth, weight, trophicity, vital status.
Results: Seroprevalence of HIV infection was 3.4%. The average age of the patients was 31.6 years. They exercised in the informal sector in 61% of the cases and had a majority of Ivorian nationality (82%). The CD4 count was less than 350 in 34% of the cases and delivery was 57% of the cases vaginally. Most newborns were born at term (72%), with a birth weight of between 2500 and 3500 grams in the vast majority of cases (73%). These neonates were stillborn in 11% of cases and the factors associated with death were CD4 count <350 items / ml (p = 0.008), lack of ARV treatment in the mother (P = 0). , 0022) and caesarean section for obstetric emergencies (p = 0.02)
Conclusion: The prevalence of HIV in pregnant women who are delivered at the CHU maternity hospital in Cocody is below the national average. This infection prevails in underprivileged environments or more than one four are not on ARV treatment with the risk of fetal death. Efforts remain to be made in the management of HIV-positive pregnant women. These efforts must focus on raising awareness among the population in order to make them accept the disease and benefit from early treatment.

Download PDF: 
DOI: 
http://dx.doi.org/10.24327/ijcar.2018. 16512.3055
Select Volume: 
Volume7